English
en left-to-right
Decision support. ChironAI drafts the SOAP note from the consultation context. The clinician edits, attests, and signs every note before it enters the chart. ChironAI does not make a regulatory clearance claim; see Disclosures.
ChironAI CDSDocumentation
Drafted from the encounter. Signed by the physician.
Chiron drafts the SOAP note from the encounter, and the physician reviews and signs it. Each drafted statement is stored with the chart field, value and date it was drawn from. Nothing is final until the physician signs. Twelve output languages. Versioned. Cryptographically signed.
ChironAI CDS
Drafted from the chart, signed by the physician.
cds.chirongrid.ai
Drafted SOAP note
What a chart-ready note looks like.
ChironAI™ CDSSOAP note · follow-up visit · T2DM
Must review before final
Decision-support output. Clinician review and attestation required before this content is signed into the chart.
Drafting the assessment · streaming
A1c improved from 8.1 to 7.4 over two visits; blood pressure at goal. Drafting each assessment line from the values recorded in the chart as it composes, so the note stays
Subjective
58-year-old female with type 2 diabetes returns for routine follow-up. Reports adherence to metformin 1000 mg BID. Self-monitored fasting glucoses 140–180 mg/dL. No hypoglycemic episodes. No polyuria, no visual changes. Diet adherence intermittent; exercise sporadic.
Objective
BP 138/86, HR 78, BMI 32.4. Heart and lung exam unremarkable. Diabetic foot exam: protective sensation intact bilaterally; no ulcers.
Assessment
A1c 7.8% — above target (< 7.0% for this patient profile per ADA Standards of Care 2026).
eGFR 78 mL/min/1.73m² with no microalbuminuria — stable kidney function, supportive of intensified glucose-lowering therapy.
Blood pressure above ADA 2026 target (<130/80) for this patient with diabetes — hypertension management warrants intensification.
Plan
- 1.Add empagliflozin 10 mg daily (SGLT2-i preferred per ADA 2026 for T2DM with elevated BP and adequate eGFR).
- 2.Increase lisinopril from 10 mg to 20 mg daily for BP control.
- 3.Re-check A1c, BMP, UACR in 3 months.
- 4.Nutrition counseling referral; patient agrees.
- 5.Diabetic eye exam due (last 14 months ago).
Draft — ChironPhysician attestsSigned to chart
Ambient scribe
From the captured encounter to a structured chart.
The ambient scribe turns the captured encounter into a structured chart draft — mapped into the visit’s sections and staged for the physician to attest. Chiron does the transcription-to-structure work; the clinician keeps the pen.
As with every artifact in ChironAI, the scribe produces a draft, not a signed note. It enters the must-review-before-final gate like everything else, and nothing reaches the chart until the physician signs.
Twelve output languages
The same SOAP note, in the patient’s language.
العربية
ar right-to-left
Deutsch
de left-to-right
Español
es left-to-right
Français
fr left-to-right
हिन्दी
hi left-to-right
Italiano
it left-to-right
日本語
ja left-to-right
한국어
ko left-to-right
Português
pt left-to-right
اردو
ur right-to-left
中文
zh left-to-right
Multi-language output is not translation of an English note after the fact. The note is drafted directly in the clinician’s chosen language.
Versioning + signatures
Immutable history. Verifiable integrity.
Every signed document gets a SHA-256 hash of its content at signature time, captured alongside the signing clinician’s identity and timestamp. Any subsequent modification of the content fails hash verification.
Amendments to signed documents are recorded as new versions; the original signed version stays verifiable end to end. The audit chain stamps each version, so forensic reconstruction is always possible.
A signing queue steps through the drafts waiting at the close of day. Each one is reviewed and signed individually, with an identity check at signature.
A note to the reader